Tosca Melissa 4
4 · KIORA PHARMACEUTICALS INC · Filed Oct 3, 2023
Insider Transaction Report
Form 4
Transactions
- Award
Stock Option (right to buy)
2023-09-29+60,000→ 60,000 totalExercise: $0.57From: 2023-09-29Exp: 2033-09-29→ Common Stock (60,000 underlying) - Award
Common Stock
2023-09-29+30,000→ 34,900 total
Footnotes (2)
- [F1]Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date.
- [F2]The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.